日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

CD8+ T cells in the tumor microenvironment modulate the response to endocrine therapy in breast cancer.

肿瘤微环境中的 CD8+ T 细胞调节乳腺癌对内分泌治疗的反应。

期刊:Journal of Clinical Investigation
影响因子:13.6
doi:10.1172/JCI188458
Napolitano Fabiana, Wang Yunguan, Sudhan Dhivya R, Gonzalez-Ericsson Paula I, Formisano Luigi, Unni Nisha, Shakeel Shahbano, Zhu James Z, Ahuja Khushi, Guo Lei, Chica-Parrado María Rosario, Matsunaga Yuki, Luna Pamela, Lin Chang-Ching A, Uemoto Yasuaki, Lee Kyung-Min, Ma Hongli, Evans Nathaniel J, Servetto Alberto, Mendiratta Saurabh, Barnes Spencer D, Bianco Roberto, Fang Yisheng V, Xu Lin, Lee Jeon, Wang Tao, Balko Justin M, Mills Gordon B, Labrie Marilyne, Hanker Ariella B, Arteaga Carlos L
乳腺癌
细胞生物学
T细胞
CD8
肿瘤微环境
发表日期：2026
文献求助 收藏

Crizotinib in Patients with Tumors with MET Amplification or Exon 14 Deletion: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocols C1 and C2

克唑替尼治疗MET扩增或14号外显子缺失的肿瘤患者：NCI-MATCH ECOG-ACRIN试验（EAY131）C1和C2子方案的结果

期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-25-1247
Coleman, Niamh; Wei, Zihan; Iafrate, A John; Zwiebel, James A; Sharon, Elad; Gray, Robert J; Wang, Victoria; McShane, Lisa M; Rubinstein, Larry V; Patton, David R; Williams, P Mickey; Hamilton, Stanley R; Takebe, Naoko; Williams, Travis; Croley, Jessica J; Onitilo, Adedayo A; Tricoli, James V; Cheng, Ju; Karlovich, Chris; Conley, Barbara A; Arteaga, Carlos L; Harris, Lyndsay; O'Dwyer, Peter J; Hong, David S; Chen, Alice P; Flaherty, Keith T
肿瘤
MET
肿瘤免疫
发表日期：2026
文献求助 收藏

Phase II Study of Dabrafenib and Trametinib in Patients With Tumors With BRAF(V600E) Mutations: Updated Results From NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol H

达拉非尼和曲美替尼治疗BRAF(V600E)突变肿瘤患者的II期研究：NCI-MATCH ECOG-ACRIN试验(EAY131)子方案H的最新结果

期刊:Jco Precision Oncology
影响因子:5.6
doi:10.1200/PO-25-00338
Salama, April K S; Wang, Victoria; Macrae, Erin R; Park, Jong-In; Chen, Helen X; Gray, Robert J; McShane, Lisa M; Rubinstein, Larry V; Patton, David; Williams, P Mickey; Hamilton, Stanley R; Armstrong, Deborah K; Tricoli, James V; Conley, Barbara A; Arteaga, Carlos L; Harris, Lyndsay N; O'Dwyer, Peter J; Chen, Alice P; Flaherty, Keith T
肿瘤
BRAF
肿瘤免疫
发表日期：2026
文献求助 收藏

Larotrectinib in Patients With Tumors With NTRK Fusions: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol EAY131-Z1E

拉罗替尼治疗NTRK融合肿瘤患者：NCI-MATCH ECOG-ACRIN试验（EAY131）子方案EAY131-Z1E的结果

期刊:Jco Precision Oncology
影响因子:5.6
doi:10.1200/PO-25-00612
Akhave, Neal; Song, Zihe; Hong, David S; Gray, Robert J; Wang, Victoria; McShane, Lisa M; Rubinstein, Larry V; Patton, David R; Williams, P Mickey; Hamilton, Stanley R; Takebe, Naoko; Tricoli, James V; Conley, Barbara A; Arteaga, Carlos L; Harris, Lyndsay N; O'Dwyer, Peter J; Chen, Alice P; Flaherty, Keith T
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

A novel engineered skin closes full thickness burn wounds: A case report

一种新型工程皮肤可封闭全层烧伤创面：病例报告

期刊:
影响因子:
doi:10.1016/j.jpra.2026.03.027
Akbarzadeh, Shiva; Zvi, Elad; Arellano, Carlos L; Banakh, Ilia; Rahman, Md M; Marks, Denese C; Lo, Cheng H; Boyce, Steven T; Bertinetti, Monique; Teague, Warwick; Cleland, Heather
发表日期：2026
文献求助 收藏

First person – Qingran Huo

第一人称——霍清然

期刊:Nature
影响因子:48.5
doi:10.1038/nature13497
Araya, Carlos L; Kawli, Trupti; Kundaje, Anshul; Jiang, Lixia; Wu, Beijing; Vafeados, Dionne; Terrell, Robert; Weissdepp, Peter; Gevirtzman, Louis; Mace, Daniel; Niu, Wei; Boyle, Alan P; Xie, Dan; Ma, Lijia; Murray, John I; Reinke, Valerie; Waterston, Robert H; Snyder, Michael
发表日期：2025
文献求助 收藏

Palliative and End-of-Life Care During Critical Cardiovascular Illness: A Scientific Statement From the American Heart Association

危重心血管疾病期间的姑息治疗和临终关怀：美国心脏协会科学声明

期刊:Circulation
影响因子:38.6
doi:10.1161/CIR.0000000000001334
Bohula, Erin A; Landzberg, Michael J; Menon, Venu; Alviar, Carlos L; Barsness, Gregory W; Crousillat, Daniela R; Jain, Nelia; Page, Robert 2nd; Wells, Rachel; Damluji, Abdulla A
心血管疾病
心血管
发表日期：2025
文献求助 收藏

ZMYND8 drives HER2 antibody resistance in breast cancer via lipid control of IL-27.

ZMYND8 通过脂质控制 IL-27 驱动乳腺癌中的 HER2 抗体耐药性

期刊:Nature Communications
影响因子:15.7
doi:10.1038/s41467-025-59184-5
Wang Yong, Wang Yanan, Bao Lei, Vale Goncalo, McDonald Jeffrey G, Fang Yisheng, Peng Yan, Kumar Ashwani, Xing Chao, Brasó-Maristany Fara, Prat Aleix, Arteaga Carlos L, Wang Yingfei, Luo Weibo
肿瘤
乳腺癌
发表日期：2025
文献求助 收藏

A bedside-to-bench translational analysis of NF1 alterations and CDK4/6 inhibitor resistance in hormone receptor-positive metastatic breast cancer.

从临床到实验室的转化分析：激素受体阳性转移性乳腺癌中 NF1 改变和 CDK4/6 抑制剂耐药性

期刊:EBioMedicine
影响因子:10.8
doi:10.1016/j.ebiom.2025.105828
Lloyd Maxwell R, Chica-Parrado Rosario, Weipert Caroline M, Knepper Todd C, Podany Emily L, Napolitano Fabiana, Ye Dan, Lin Chang-Ching, Uemoto Yasuaki, Liao Jiemin, Wegrzyn Claire, Walko Christine M, Ryan Lianne Y, Keenan Jennifer C, Medford Arielle J, Liu Shiyuan A, Wulf Gerburg M, Clifton Katherine K, Ma Cynthia X, Han Hyo S, Zhang Nicole, Ellisen Leif W, Bardia Aditya, Arteaga Carlos L, Hanker Ariella B, Wander Seth A
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Phase II Study of Palbociclib in Patients with Tumors with CDK4 or CDK6 Amplification: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol Z1C

帕博西尼治疗 CDK4 或 CDK6 扩增肿瘤患者的 II 期研究：NCI-MATCH ECOG-ACRIN 试验 (EAY131) 子方案 Z1C 的结果

期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-24-0036
O'Hara, Mark H; Jegede, Opeyemi; Dickson, Mark A; DeMichele, Angela M; Piekarz, Richard; Gray, Robert J; Wang, Victoria; McShane, Lisa M; Rubinstein, Lawrence V; Patton, David R; Williams, P Mickey; Hamilton, Stanley R; Onitilo, Adedayo; Tricoli, James V; Conley, Barbara A; Arteaga, Carlos L; Harris, Lyndsay N; O'Dwyer, Peter J; Chen, Alice P; Flaherty, Keith T
CDK4
肿瘤
肿瘤免疫
CDK6
发表日期：2025
文献求助 收藏